WILSON JAMES N
Director
- Shares
- 300
- Price
- $116.30
- Value
- $34,889
CORT
9 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$53,948,830
0 buyers · 9 sellers
12-month purchases
$3,313,809
1 distinct insiders
12-month sales
$101,545,834
10 distinct insiders
Highlighted alerts
7
93 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
CORT overview: breakout setup, X sentiment and insiders in one page →
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
Includes 179 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 396 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 138 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on June 17, 2026, prior to the Reporting Person being appointed an officer of the Issuer, which was in effect at the time of this transaction. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $114.03 to $114.90 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $115.16 to $116.04 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.24 to $117.22 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. Shares subject to the stock option vested and became exercisable with respect to 25% of the shares underlying the option on January 29, 2025 with the remaining shares vesting and becoming exercisable ratably on a monthly basis over a period of 36 consecutive months thereafter until fully vested and exercisable on January 29, 2028, subject to the Reporting Person's continued service.
Reason: administrative_code. The trade is reported under a Rule 10b5-1 plan.
Voluntary purchases and sales; administrative noise stays hidden.
WILSON JAMES N
Director
WILSON JAMES N
Director
WILSON JAMES N
Director
Vieira Roberto Wandenkolk
President, Oncology
Vieira Roberto Wandenkolk
President, Oncology
Vieira Roberto Wandenkolk
President, Oncology
Lyon Joseph Douglas
See Remarks
Lyon Joseph Douglas
See Remarks
Maduck Sean
See Remarks
Maduck Sean
See Remarks
Lyon Joseph Douglas
See Remarks
Maduck Sean
See Remarks
Vieira Roberto Wandenkolk
President, Oncology
WILSON JAMES N
Director
WILSON JAMES N
Director
WILSON JAMES N
Director
Lyon Joseph Douglas
See Remarks
Lyon Joseph Douglas
See Remarks
Vieira Roberto Wandenkolk
President, Oncology
Vieira Roberto Wandenkolk
President, Oncology
Vieira Roberto Wandenkolk
President, Oncology
Vieira Roberto Wandenkolk
President, Oncology
Vieira Roberto Wandenkolk
President, Oncology
Vieira Roberto Wandenkolk
President, Oncology
Vieira Roberto Wandenkolk
President, Oncology
Maduck Sean
See Remarks
Maduck Sean
See Remarks
Maduck Sean
See Remarks
Park Kimberly
Director
Maduck Sean
See Remarks
Maduck Sean
See Remarks
MAHONEY DAVID L
Director
MAHONEY DAVID L
Director
MAHONEY DAVID L
Director
MAHONEY DAVID L
Director
Robb Gary Charles
Chief Business Officer
Maduck Sean
See Remarks
WILSON JAMES N
Director
WILSON JAMES N
Director
WILSON JAMES N
Director
Maduck Sean
See Remarks
Guyer William
Chief Development Officer
Guyer William
Chief Development Officer
Guyer William
Chief Development Officer
Maduck Sean
See Remarks
Lyon Joseph Douglas
See Remarks
Mokari Atabak
Chief Financial Officer
Mokari Atabak
Chief Financial Officer
Mokari Atabak
Chief Financial Officer
Mokari Atabak
Chief Financial Officer
Mokari Atabak
Chief Financial Officer
Mokari Atabak
Chief Financial Officer
Mokari Atabak
Chief Financial Officer
Mokari Atabak
Chief Financial Officer
Mokari Atabak
Chief Financial Officer
Mokari Atabak
Chief Financial Officer
Mokari Atabak
Chief Financial Officer
Mokari Atabak
Chief Financial Officer
Mokari Atabak
Chief Financial Officer
WILSON JAMES N
Director
WILSON JAMES N
Director
WILSON JAMES N
Director
WILSON JAMES N
Director
Mokari Atabak
Chief Financial Officer
Mokari Atabak
Chief Financial Officer
Mokari Atabak
Chief Financial Officer
Mokari Atabak
Chief Financial Officer
Guyer William
Chief Development Officer
Guyer William
Chief Development Officer
Maduck Sean
See Remarks
Maduck Sean
See Remarks
Maduck Sean
See Remarks
MAHONEY DAVID L
Director
WILSON JAMES N
Director
WILSON JAMES N
Director
Mokari Atabak
Chief Financial Officer
Mokari Atabak
Chief Financial Officer
Mokari Atabak
Chief Financial Officer
Mokari Atabak
Chief Financial Officer
Guyer William
Chief Development Officer
Maduck Sean
See Remarks
Maduck Sean
See Remarks
Mokari Atabak
Chief Financial Officer
BELANOFF JOSEPH K
Chief Executive Officer
Lyon Joseph Douglas
See Remarks
Maduck Sean
See Remarks
Maduck Sean
See Remarks
Guyer William
Chief Development Officer
BELANOFF JOSEPH K
Chief Executive Officer
Guyer William
Chief Development Officer
BELANOFF JOSEPH K
Chief Executive Officer
Guyer William
Chief Development Officer
BAKER G LEONARD JR
Director
BAKER G LEONARD JR
Director
Guyer William
Chief Development Officer
Guyer William
Chief Development Officer
Guyer William
Chief Development Officer
Guyer William
Chief Development Officer
Guyer William
Chief Development Officer
Maduck Sean
See Remarks
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | WILSON JAMES N Director | Sale | 300 | $116.30 | $34,889 | |
| Oct 15, 2026 | WILSON JAMES N Director | Sale | 3,046 | $115.39 | $351,476 | |
| Oct 15, 2026 | WILSON JAMES N Director | Sale | 6,654 | $114.48 | $761,717 | |
| Oct 02, 2026 | Vieira Roberto Wandenkolk President, Oncology | Sale | 5,147 | $116.59 | $600,063 | |
| Oct 02, 2026 | Vieira Roberto Wandenkolk President, Oncology | Sale | 2,086 | $115.73 | $241,412 | |
| Oct 02, 2026 | Vieira Roberto Wandenkolk President, Oncology | Sale | 1,100 | $114.52 | $125,973 | |
| Oct 02, 2026 | Lyon Joseph Douglas See Remarks | Sale | 4,744 | $116.54 | $552,869 | |
| Oct 02, 2026 | Lyon Joseph Douglas See Remarks | Sale | 4,446 | $115.70 | $514,389 | |
| Oct 02, 2026 | Maduck Sean See Remarks | Sale | 8,744 | $116.55 | $1,019,143 | |
| Oct 02, 2026 | Maduck Sean See Remarks | Sale | 15,843 | $116.12 | $1,839,741 | |
| Oct 01, 2026 | Lyon Joseph Douglas See Remarks | Sale | 810 | $115.40 | $93,473 | |
| Oct 01, 2026 | Maduck Sean See Remarks | Sale | 413 | $115.54 | $47,717 | |
| Sep 16, 2026 | Vieira Roberto Wandenkolk President, Oncology | Sale | 296 | $100.82 | $29,843 | |
| Sep 15, 2026 | WILSON JAMES N Director | Sale | 2,800 | $111.70 | $312,771 | |
| Sep 15, 2026 | WILSON JAMES N Director | Sale | 400 | $110.84 | $44,335 | |
| Sep 15, 2026 | WILSON JAMES N Director | Sale | 6,800 | $110.27 | $749,835 | |
| Sep 14, 2026 | Lyon Joseph Douglas See Remarks | Sale | 2,188 | $114.12 | $249,686 | |
| Sep 14, 2026 | Lyon Joseph Douglas See Remarks | Sale | 7,812 | $113.32 | $885,261 | |
| Sep 02, 2026 | Vieira Roberto Wandenkolk President, Oncology | Sale | 5,621 | $114.58 | $644,042 | |
| Sep 02, 2026 | Vieira Roberto Wandenkolk President, Oncology | Sale | 1,606 | $113.72 | $182,632 | |
| Sep 02, 2026 | Vieira Roberto Wandenkolk President, Oncology | Sale | 974 | $112.40 | $109,474 | |
| Sep 02, 2026 | Vieira Roberto Wandenkolk President, Oncology | Sale | 1,537 | $111.37 | $171,181 | |
| Sep 02, 2026 | Vieira Roberto Wandenkolk President, Oncology | Sale | 23,770 | $110.70 | $2,631,349 | |
| Sep 02, 2026 | Vieira Roberto Wandenkolk President, Oncology | Sale | 23,600 | $109.35 | $2,580,674 | |
| Sep 02, 2026 | Vieira Roberto Wandenkolk President, Oncology | Sale | 1,225 | $115.44 | $141,413 | |
| Sep 01, 2026 | Maduck Sean See Remarks | Sale | 2,281 | $115.61 | $263,711 | |
| Sep 01, 2026 | Maduck Sean See Remarks | Sale | 10,989 | $114.71 | $1,260,568 | |
| Sep 01, 2026 | Maduck Sean See Remarks | Sale | 11,730 | $113.94 | $1,336,459 | |
| Aug 26, 2026 | Park Kimberly Director | Sale | 26,685 | $122.55 | $3,270,169 | |
| Aug 25, 2026 | Maduck Sean See Remarks | Sale | 5,870 | $126.06 | $739,965 | |
| Aug 25, 2026 | Maduck Sean See Remarks | Sale | 25,085 | $125.47 | $3,147,355 | |
| Aug 18, 2026 | MAHONEY DAVID L Director | Sale | 400 | $119.64 | $47,855 | |
| Aug 18, 2026 | MAHONEY DAVID L Director | Sale | 7,055 | $118.88 | $838,710 | |
| Aug 18, 2026 | MAHONEY DAVID L Director | Sale | 91,167 | $118.24 | $10,779,367 | |
| Aug 18, 2026 | MAHONEY DAVID L Director | Sale | 4,984 | $117.47 | $585,478 | |
| Aug 17, 2026 | Robb Gary Charles Chief Business Officer | Sale | 10,000 | $116.26 | $1,162,572 | |
| Aug 14, 2026 | Maduck Sean See Remarks | Sale | 3,664 | $114.49 | $419,491 | |
| Aug 14, 2026 | WILSON JAMES N Director | Sale | 2,279 | $112.64 | $256,706 | |
| Aug 14, 2026 | WILSON JAMES N Director | Sale | 4,668 | $111.44 | $520,214 | |
| Aug 14, 2026 | WILSON JAMES N Director | Sale | 3,053 | $110.49 | $337,341 | |
| Aug 10, 2026 | Maduck Sean See Remarks | Sale | 1,031 | $114.52 | $118,068 | |
| Aug 10, 2026 | Guyer William Chief Development Officer | Sale | 4,770 | $114.04 | $543,957 | |
| Aug 10, 2026 | Guyer William Chief Development Officer | Sale | 11,530 | $113.18 | $1,304,933 | |
| Aug 04, 2026 | Guyer William Chief Development Officer | Sale | 3,700 | $113.12 | $418,562 | |
| Aug 03, 2026 | Maduck Sean See Remarks | Sale | 20,305 | $114.70 | $2,329,075 | |
| Aug 03, 2026 | Lyon Joseph Douglas See Remarks | Sale | 1,540 | $114.16 | $175,806 | |
| Jul 30, 2026 | Mokari Atabak Chief Financial Officer | Sale | 7,089 | $116.96 | $829,102 | |
| Jul 30, 2026 | Mokari Atabak Chief Financial Officer | Sale | 14,222 | $115.87 | $1,647,859 | |
| Jul 30, 2026 | Mokari Atabak Chief Financial Officer | Sale | 15,477 | $114.96 | $1,779,237 | |
| Jul 30, 2026 | Mokari Atabak Chief Financial Officer | Sale | 4,700 | $113.18 | $531,941 | |
| Jul 30, 2026 | Mokari Atabak Chief Financial Officer | Sale | 600 | $110.95 | $66,570 | |
| Jul 30, 2026 | Mokari Atabak Chief Financial Officer | Sale | 2,202 | $110.03 | $242,282 | |
| Jul 30, 2026 | Mokari Atabak Chief Financial Officer | Sale | 400 | $108.46 | $43,384 | |
| Jul 30, 2026 | Mokari Atabak Chief Financial Officer | Sale | 8,956 | $106.96 | $957,892 | |
| Jul 30, 2026 | Mokari Atabak Chief Financial Officer | Sale | 1,001 | $120.67 | $120,796 | |
| Jul 30, 2026 | Mokari Atabak Chief Financial Officer | Sale | 8,103 | $119.95 | $971,939 | |
| Jul 30, 2026 | Mokari Atabak Chief Financial Officer | Sale | 4,783 | $118.73 | $567,908 | |
| Jul 30, 2026 | Mokari Atabak Chief Financial Officer | Sale | 8,267 | $117.93 | $974,951 | |
| Jul 30, 2026 | Mokari Atabak Chief Financial Officer | Sale | 4,200 | $105.54 | $443,248 | |
| Jul 15, 2026 | WILSON JAMES N Director | Sale | 1,978 | $89.49 | $177,007 | |
| Jul 15, 2026 | WILSON JAMES N Director | Sale | 2,974 | $88.81 | $264,122 | |
| Jul 15, 2026 | WILSON JAMES N Director | Sale | 3,969 | $87.74 | $348,223 | |
| Jul 15, 2026 | WILSON JAMES N Director | Sale | 1,079 | $86.78 | $93,633 | |
| Jul 15, 2026 | Mokari Atabak Chief Financial Officer | Sale | 101 | $89.43 | $9,032 | |
| Jul 15, 2026 | Mokari Atabak Chief Financial Officer | Sale | 3,520 | $88.30 | $310,822 | |
| Jul 15, 2026 | Mokari Atabak Chief Financial Officer | Sale | 28,460 | $87.89 | $2,501,244 | |
| Jul 15, 2026 | Mokari Atabak Chief Financial Officer | Sale | 7,919 | $86.78 | $687,179 | |
| Jul 07, 2026 | Guyer William Chief Development Officer | Sale | 952 | $93.54 | $89,048 | |
| Jul 07, 2026 | Guyer William Chief Development Officer | Sale | 19,048 | $93.11 | $1,773,481 | |
| Jul 01, 2026 | Maduck Sean See Remarks | Sale | 11,175 | $89.31 | $998,033 | |
| Jul 01, 2026 | Maduck Sean See Remarks | Sale | 2,801 | $88.51 | $247,924 | |
| Jul 01, 2026 | Maduck Sean See Remarks | Sale | 11,024 | $87.33 | $962,780 | |
| Jun 17, 2026 | MAHONEY DAVID L Director | Sale | 20,000 | $84.53 | $1,690,506 | |
| Jun 16, 2026 | WILSON JAMES N Director | Sale | 5,823 | $83.57 | $486,633 | |
| Jun 16, 2026 | WILSON JAMES N Director | Sale | 4,177 | $82.69 | $345,416 | |
| Jun 15, 2026 | Mokari Atabak Chief Financial Officer | Sale | 2 | $82.45 | $164.90 | |
| Jun 15, 2026 | Mokari Atabak Chief Financial Officer | Sale | 19,483 | $81.81 | $1,593,889 | |
| Jun 15, 2026 | Mokari Atabak Chief Financial Officer | Sale | 11,081 | $80.94 | $896,923 | |
| Jun 15, 2026 | Mokari Atabak Chief Financial Officer | Sale | 9,434 | $80.02 | $754,924 | |
| Jun 02, 2026 | Guyer William Chief Development Officer | Sale | 20,000 | $70.60 | $1,412,000 | |
| Jun 01, 2026 | Maduck Sean See Remarks | Sale | 3,931 | $70.75 | $278,103 | |
| Jun 01, 2026 | Maduck Sean See Remarks | Sale | 21,069 | $70.11 | $1,477,080 | |
| Jun 01, 2026 | Mokari Atabak Chief Financial Officer | Sale | 40,000 | $70.00 | $2,800,004 | |
| Jun 01, 2026 | BELANOFF JOSEPH K Chief Executive Officer | Sale | 12,837 | $69.74 | $895,252 | |
| May 27, 2026 | Lyon Joseph Douglas See Remarks | Sale | 5,000 | $65.00 | $325,000 | |
| May 27, 2026 | Maduck Sean See Remarks | Sale | 20,425 | $66.16 | $1,351,316 | |
| May 27, 2026 | Maduck Sean See Remarks | Sale | 54,575 | $65.37 | $3,567,628 | |
| May 05, 2026 | Guyer William Chief Development Officer | Sale | 20,000 | $51.83 | $1,036,600 | |
| May 01, 2026 | BELANOFF JOSEPH K Chief Executive Officer | Sale | 40,000 | $50.10 | $2,003,860 | |
| Apr 07, 2026 | Guyer William Chief Development Officer | Sale | 20,000 | $40.97 | $819,400 | |
| Mar 25, 2026 | BELANOFF JOSEPH K Chief Executive Officer | Sale | 26,198 | $50.07 | $1,311,826 | |
| Mar 20, 2026 | Guyer William Chief Development Officer | Sale | 11,767 | $36.01 | $423,730 | |
| Mar 17, 2026 | BAKER G LEONARD JR Director | Purchase | 24,218 | $33.56 | $812,836 | |
| Mar 17, 2026 | BAKER G LEONARD JR Director | Purchase | 75,782 | $33.00 | $2,500,973 | |
| Mar 04, 2026 | Guyer William Chief Development Officer | Sale | 8,233 | $35.99 | $296,346 | |
| Feb 03, 2026 | Guyer William Chief Development Officer | Sale | 20,000 | $40.87 | $817,334 | |
| Jan 06, 2026 | Guyer William Chief Development Officer | Sale | 20,000 | $35.18 | $703,656 | |
| Dec 02, 2025 | Guyer William Chief Development Officer | Sale | 640 | $80.88 | $51,760 | |
| Dec 02, 2025 | Guyer William Chief Development Officer | Sale | 19,360 | $80.05 | $1,549,766 | |
| Dec 01, 2025 | Maduck Sean See Remarks | Sale | 20,000 | $79.52 | $1,590,490 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.